BioArray Solutions

New York, United States Founded: 2001 • Age: 25 yrs Acquired By Immucor
Bead-based assays for nucleic acid and protein analysis are developed.
Request Access

About BioArray Solutions

BioArray Solutions is a company based in New York (United States) founded in 2001 was acquired by Immucor in March 2008.. BioArray Solutions has raised $11.83 million across 2 funding rounds from investors including Immucor. BioArray Solutions operates in a competitive market with competitors including Inflammatix, StrideBio, Agendia, LogicBio and Phase Genomics, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $11.83 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.31 M (USD), Series B

    Jun 01, 2005

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Immucor

    (Mar 11, 2008)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of BioArray Solutions

BioArray Solutions has successfully raised a total of $11.83M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $1.31 million completed in June 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series B — $1.3M
  • First Round

    (01 Jan 2005)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2005 Amount Series B - BioArray Solutions Valuation

investors

Jan, 2005 Amount Series B - BioArray Solutions Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BioArray Solutions

BioArray Solutions has secured backing from 1 investor. Prominent investors backing the company include Immucor. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Transfusion and transplantation diagnostic products are provided by Immucor.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BioArray Solutions

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - BioArray Solutions

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bioarray Solutions Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BioArray Solutions

BioArray Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, StrideBio, Agendia, LogicBio and Phase Genomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of diagnostic solutions for systemic infections
domain founded_year HQ Location
AAV-based gene therapies for rare diseases are developed.
domain founded_year HQ Location
Genomic diagnostic products for cancer treatment are provided.
domain founded_year HQ Location
Viral vectors are developed for genetic and infectious disease treatments.
domain founded_year HQ Location
Laboratory and computational services for DNA proximity analysis are provided.
domain founded_year HQ Location
Viral immunotherapies are developed for cancer treatment.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bioarray Solutions

Frequently Asked Questions about BioArray Solutions

When was BioArray Solutions founded?

BioArray Solutions was founded in 2001 and raised its 1st funding round 4 years after it was founded.

Where is BioArray Solutions located?

BioArray Solutions is headquartered in New York, United States. It is registered at New York, New York, United States.

Is BioArray Solutions a funded company?

BioArray Solutions is a funded company, having raised a total of $11.83M across 2 funding rounds to date. The company's 1st funding round was a Series B of $10.52M, raised on Jan 01, 2005.

What does BioArray Solutions do?

BioArray Solutions was founded in 2001 in New York, United States, within the biotechnology sector. Bead-based assays for nucleic acid and protein analysis are developed, along with products for genetic diagnostics and infectious disease profiling. The BeadChip system, featuring encoded microparticles for molecular analysis, has received FDA clearance for an autoantibody profiling assay. The company was acquired by Immucor in March 2008.

Who are the top competitors of BioArray Solutions?

BioArray Solutions's top competitors include Inflammatix, Phase Genomics and Genedit.

Who are BioArray Solutions's investors?

BioArray Solutions has 1 investor. Key investors include Immucor.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available